$35.92 0.72 (+2.05%)
2/13/2012 4:00 PM

Endo Pharmaceuticals (NASDAQ:ENDP)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

Recs

8
Player Avatar tenmiles (99.96) Submitted: 4/2/2009 10:18:12 AM : Outperform Start Price: $18.04 ENDP Score: +35.04

Adding a little Percocet to the portfolio. Pharma dealing with various pain control products offers strong balance sheet with high ROE; likely to show relative strength later in the summer in advance of FDA decision on marketing application for NEBIDO - buyer around $18

Report this Post 1 Comment
Member Avatar wallstreetbean (98.90) Submitted: 5/20/2009 11:29:38 AM
Recs: 0

I'm hoping to pick this up around $15 for my real portfolio, but $16 isn't too bad for my CAPS entry. :) Carries quite a bit of debt, but cash flow looks good.

Featured Broker Partners


Advertisement